|Offre||0,00 x 800|
|Vente||0,00 x 800|
|Var. jour||131,89 - 133,29|
|Sur 52 semaines||120,40 - 158,34|
|Volume moyen||1 140 469|
|Bêta (mensuel sur 5 ans)||0,94|
|Rapport P/E (sur 12 mois)||16,68|
|BPA (sur 12 mois)||7,97|
|Date de bénéfices||19 avr. 2023 - 24 avr. 2023|
|Dividende et rendement à terme||2,84 (2,16 %)|
|Date ex-dividende||06 avr. 2023|
|Objectif sur 1 an||149,71|
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Quest Diagnostics Healthy NewsWorks Healthy NewsWorks (HNW) empowers elementary and middle-school students to advocate for health literacy through school-based journalism programs. HNW provides ...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest Diagnostics, completing a transition first announced on February 3, 2022.
According to the Association of American Medical Colleges, only 8% of medical students and 5% of physicians are Black and African American.